Next Article in Journal
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
Next Article in Special Issue
Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary Disease
Previous Article in Journal
Enhancing the Antipsychotic Effect of Risperidone by Increasing Its Binding Affinity to Serotonin Receptor via Picric Acid: A Molecular Dynamics Simulation
Previous Article in Special Issue
Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study
 
 
Article
Peer-Review Record

Tumor Necrosis Factor-α Mediates Lung Injury in the Early Phase of Endotoxemia

Pharmaceuticals 2022, 15(3), 287; https://doi.org/10.3390/ph15030287
by Kung-Yen Chen 1,2,3, Chao-Yuan Chang 2,3,4, Hao-Jen Hsu 5, Hung-Jen Shih 6,7,8, I-Tao Huang 9,10, Hemal H. Patel 11,12,*,† and Chun-Jen Huang 1,2,3,13,*,†
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pharmaceuticals 2022, 15(3), 287; https://doi.org/10.3390/ph15030287
Submission received: 14 February 2022 / Accepted: 18 February 2022 / Published: 24 February 2022
(This article belongs to the Special Issue Lung Injury and Repair)

Round 1

Reviewer 1 Report

I have revised the manuscript and all my questions have been answered by the authors. I do not have any additional comments and think the manuscript can be accepted for publication. 

Reviewer 2 Report

I think this paper has been well revised.

Back to TopTop